Ontvang nu dagelijks onze kooptips!

word abonnee
Van beleggers
voor beleggers
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
Markt vandaag Koersen Forum Premium IEX Expert
Home  /   Forum   /   Amerikaanse aandelen   /   Multicell Technologies Inc (mcet)

Amerikaanse aandelen« Terug naar discussie overzicht

Multicell Technologies Inc (mcet)

Volgen
53 Posts
Pagina: «« 1 2 3 | Laatste | Omlaag ↓
  5. Demenkovets 31 mei 2011 15:47
    MultiCell Technologies is Granted Stem Cell Patent
    Date : 05/31/2011 @ 8:30AM
    Source : PR Newswire

    MultiCell Technologies is Granted Stem Cell Patent

    Multicell Techs (OTCBB:MCET)
    Today : Tuesday 31 May 2011

    MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) is pleased to announce the issuance of U.S. patent 7,935,528 by the United States Patent and Trademark Office (USPTO) relating to the isolation and use of human liver stem cells to treat liver disease. Under the terms of its license agreement with Rhode Island Hospital, MultiCell Technologies is the worldwide exclusive licensee of U.S. patent 7,935,528.

    The patent describes methods to isolate and use human liver stem cells to treat degenerative liver diseases, or inherited deficiencies of liver function. Patients who suffer from severe, irreversible liver disease for which other medical and surgical treatments have failed are often candidates for a liver transplant. Liver stem cells which differentiate into functional mature hepatocytes could help to reconstitute a diseased liver, and may be an alternative approach to whole organ transplants for certain liver diseases.

    "We are pleased the USPTO has agreed that our liver stem cells are indeed novel and may lead to important therapeutic applications," said W. Gerald Newmin, Chairman and Chief Executive Officer. "Our efforts to better understand liver stem cell biology, and the role these cells play in chronic liver disease and primary hepatocellular carcinoma, is a major focus of the Company," Mr. Newmin stated.
53 Posts
Pagina: «« 1 2 3 | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Markt Vandaag

Stijgers

instrument koers absoluut verschil relatief verschil
ACOMO 21,000 +1,90 +9,95%
Kendrion 10,740 +0,83 +8,38%
CM.COM 6,470 +0,42 +6,94%
WDP 20,980 +1,03 +5,16%
Accsys 0,535 +0,02 +3,28%
KPN 3,704 +0,11 +2,92%
AALBERTS NV 36,280 +0,80 +2,25%
Eurocommercial Properties 23,700 +0,35 +1,50%
Heineken 81,360 +1,20 +1,50%
OCI 11,210 +0,16 +1,45%
UNILEVER PLC 54,800 +0,76 +1,41%
ABN AMRO BANK N.V. 19,520 +0,27 +1,40%
Sligro 10,740 +0,14 +1,32%
Nedap N.V. 61,800 +0,80 +1,31%
JDE PEET'S 18,330 +0,22 +1,21%
Wereldhave 15,280 +0,18 +1,19%
Ahold Delhaize 34,110 +0,40 +1,19%
Fagron 18,500 +0,20 +1,09%
B&S Group SA 4,120 +0,04 +0,98%
ING 18,870 +0,12 +0,66%
IMCD 137,400 +0,85 +0,62%
SHELL PLC 30,635 +0,18 +0,57%
NSI 21,450 +0,10 +0,47%
Arcadis 46,880 +0,18 +0,39%
VASTNED 27,600 +0,10 +0,36%
Wolters Kluwer 142,100 +0,40 +0,28%
RELX 43,820 +0,12 +0,27%
NN Group 48,120 +0,11 +0,23%
Van Lanschot Kempen NV 48,050 +0,05 +0,10%
BESI 101,150 +0,10 +0,10%
Philips Koninklijke 25,260 +0,01 +0,04%
ALLFUNDS GROUP 5,425 +5,43 0,00%
Avantium 1,718 +1,72 0,00%
AZERION 1,450 +1,45 0,00%
CTP 16,040 +16,04 0,00%
EBUSCO HOLDING 0,586 +0,59 0,00%
EXOR NV 92,650 +92,65 0,00%
FASTNED 19,700 +19,70 0,00%
INPOST 16,260 +16,26 0,00%
NX FILTRATION 3,270 +3,27 0,00%
PROSUS 44,275 +44,28 0,00%
RENEWI 10,120 +10,12 0,00%
Sif Holding 11,200 +11,20 0,00%
THEON INTERNAT 19,160 +19,16 0,00%
UMG 27,610 +27,61 0,00%

Dalers

instrument koers absoluut verschil relatief verschil
AMG Critical Materials N.V. 16,550 -1,43 -7,95%
ArcelorMittal 30,480 -1,69 -5,25%
Air France-KLM 11,560 -0,60 -4,93%
ADYEN NV 1.593,600 -69,00 -4,15%
TomTom 4,696 -0,17 -3,57%
Aegon 5,800 -0,13 -2,26%
HEIJMANS KON 37,900 -0,85 -2,19%
RANDSTAD NV 42,000 -0,91 -2,12%
BAM 5,180 -0,11 -2,08%
Basic-Fit 23,040 -0,46 -1,96%
Fugro 14,180 -0,22 -1,53%
Pharming 0,758 -0,01 -1,49%
Alfen N.V. 12,830 -0,17 -1,31%
Aperam 31,940 -0,40 -1,24%
PostNL 0,999 -0,01 -1,24%
ASMI 450,800 -4,90 -1,08%
Vopak 39,740 -0,32 -0,80%
DSM FIRMENICH AG 96,000 -0,72 -0,74%
TKH 38,660 -0,28 -0,72%
ASML 666,000 -4,00 -0,60%
SIGNIFY NV 20,880 -0,12 -0,57%
Galapagos 24,500 -0,12 -0,49%
Akzo Nobel 61,400 -0,22 -0,36%
Corbion 20,180 -0,04 -0,20%
ASR Nederland 50,480 -0,10 -0,20%
Brunel 10,480 -0,02 -0,19%
Flow Traders 25,700 -0,04 -0,16%
ForFarmers 4,510 -0,01 -0,11%
JUST EAT TAKEAWAY 19,410 -0,02 -0,10%
SBM Offshore 19,780 -0,01 -0,05%
vlag naam koers verschil relatief verschil
AEX 911,34 +0,62 +0,07%
AEX GR 3.585,75 +2,44 +0,07%
DE40 23.008,94 -410,54 -1,75%
FTSE 100 8.679,88 -2,96 -0,03%
Europe50^ 5.468,41 -52,06 -0,94%
US30^ 42.798,70 0,00 0,00%
Nasd100^ 20.187,80 0,00 0,00%
US500^ 5.768,30 0,00 0,00%
Japan225^ 37.281,60 0,00 0,00%
VD-NEW 24,91 +2,10 +9,22%
#/^ Index indications calculated real time, zie disclaimer